Compare ATRC & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | GAB |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2005 | N/A |
| Metric | ATRC | GAB |
|---|---|---|
| Price | $37.83 | $6.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $52.22 | N/A |
| AVG Volume (30 Days) | 538.1K | ★ 667.8K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $518,304,999.00 | N/A |
| Revenue This Year | $16.94 | N/A |
| Revenue Next Year | $12.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.80 | N/A |
| 52 Week Low | $28.29 | $4.56 |
| 52 Week High | $43.18 | $5.88 |
| Indicator | ATRC | GAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 63.16 |
| Support Level | $36.11 | $6.09 |
| Resistance Level | $38.32 | $6.19 |
| Average True Range (ATR) | 1.46 | 0.07 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 36.46 | 91.67 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.